Search Results

You are looking at 31 - 40 of 151 items for :

  • "genetic counseling" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Time Studies of the Tasks Associated with Comprehensive Cancer Genetics Counseling

Suzanne M. Mahon

visit with a genetics professional takes time (84 minutes 2 to 105 minutes 1 ); an average follow-up visit lasts 74 minutes. 2 Finding ways to efficiently provi genetic counseling services is critical in light of the limited numbers of credentialed

Full access

Time Studies of the Tasks Associated with Comprehensive Cancer Genetics Counseling

Brandie Heald and Charis Eng

document the benefit added by their services and that the field can grow and expand with the changing climate of health care. The National Society of Genetic Counselors ( ) has prioritized assessing and establishing outcome measures for genetic

Full access

BPI20-014: Clinical Pathway and Education Implementation to Support Guideline Adherent Breast Cancer Care for Rural Women Under Age 50

Robin M. Lally, Elizabeth Reed, and Roksana Zak

Background: Adherence to National Comprehensive Cancer Network (NCCN) guidelines improves breast cancer therapy outcomes. While physician guideline adherence is often high, room for improvement exists. Shared surgical decision making, genetic

Full access

QIM22-196: Participation in a Mentored Cancer Quality Improvement Collaborative Improves QI Aptitude Among Oncology Providers

Rachel Hae-Soo Joung, Brianna Marie D'Orazio, Jeana Springmann, Julie Johnson, Karl Y. Bilimoria, and Anthony D. Yang

-based genetic counseling referrals for breast cancer patients. An oncology-focused adaptation of the QI Knowledge Application Tool (QI-KAT), a validated QI assessment, was administered pre- and post-intervention. Three educators scored each de-identified exam

Full access

EPR24-111: The Clinical Effect of a Community-Based Genetic Testing Program

Danielle Brabender, Emily Siegel, Julie Culver, Jacob Comeaux, Anjali Date, and Amanda Woodworth

likely pathogenic (P/LP) variant were offered third-party genetic counseling. A descriptive analysis was conducted, utilizing NCCN v.1.2023 guidelines, to assess the potential impact on screening and risk-reducing surgery in this population. Results: A

Full access

QIM20-134: Genetic Testing for At-Risk Patients With Colorectal and/or Pancreatic Cancer at Our Institution, a Quality Improvement Project

Mina Shenouda, Vivek Yadala, Jennifer Dotson, and Toni Pacioles

is expected to cause about 45,750 deaths during 2019. The current NCCN Guidelines recommend genetic counseling and germline testing in all PC pts. This recommendation was based on evidence that germline genetic mutations were identified in 5.5% of all

Full access

Casting a Wide Net While Building a Safety Net: Addressing Disparities in Genetic Testing for Hereditary Cancer

Julie Mak

genetic counselors, available in multiple languages. Genetic counseling assistants, trained and supported by our counselors, facilitate the process. Patients can elect to see a genetic counselor or may be referred for counseling based on their responses to

Full access

Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time

Filipa Lynce and Claudine Isaacs

results; the ability of the current model of genetic counseling practices to deal with the increase in patient volume; and the cost-effectiveness of such an approach. 8 , 9 One way of minimizing the identification of VUS, the impact of false

Full access

Your Genes: Getting the Best Fit

Margaret Tempero

reducing lifestyle risks that they can actually control? Considering the expanding need, the workforce shortage in genetic counseling is increasing to epic proportions, and I don't think there is a solution in sight. So I guess this is another call to

Full access

Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative

Julia R. Trosman, Christine B. Weldon, Michael P. Douglas, Allison W. Kurian, R. Kate Kelley, Patricia A. Deverka, and Kathryn A. Phillips

despite informed consent and genetic counseling, patients may not understand the immature state of evidence about numerous genes within panels (73%) and that their data are used for research, to which many would object if better informed. Payers' suspicion